April 2012 Briefing - AllergyLast Updated: May 01, 2012.
Here are what the editors at HealthDay consider to be the most important developments in Allergy for April 2012. This roundup includes the latest research news from journal articles, as well as the FDA approvals and regulatory changes that are the most likely to affect clinical practice.
Novel Lipocalin Dog Allergen Cross-Reacts With Cat, Horse
FRIDAY, April 27 (HealthDay News) -- A novel lipocalin dog allergen has been identified in nearly 40 percent of dog-sensitized individuals, which cross-reacts with lipocalins from cat and horse, according to a study published online April 20 in Allergy.
S. Aureus, Enterotoxins ID'd in Atopic Keratoconjunctivitis
MONDAY, April 23 (HealthDay News) -- Staphylococcus aureus (S. aureus) and S. aureus-secreted enterotoxins (SE) are frequently found in patients with atopic keratoconjunctivitis (AKC), particularly in those with corneal ulceration, according to a study published online April 10 in Allergy.
IL-32 Expression Upregulated in Chronic Rhinosinusitis
MONDAY, April 16 (HealthDay News) -- Interleukin-32 (IL-32) mRNA expression is significantly higher in biopsies obtained from patients with chronic rhinosinusitis (CRS), compared to levels found in biopsies obtained from individuals without the condition, according to a study published online April 9 in Allergy.
Alternative Medicine Doesn't Affect Asthma Care in Children
TUESDAY, April 10 (HealthDay News) -- Complementary and alternative medicine (CAM) is not associated with adherence to pediatric asthma treatment, according to a study published online April 9 in Pediatrics.
Low Blood Adiponectin Predicts Future Asthma Risk in Women
FRIDAY, April 6 (HealthDay News) -- Middle-aged women with low blood adiponectin levels are about twice as likely to develop asthma, particularly if they smoke, according to a study published online April 6 in the American Journal of Respiratory and Critical Care Medicine.
Medical Malpractice Claims Incur Substantial Defense Costs
WEDNESDAY, April 4 (HealthDay News) -- Defense costs for medical malpractice claims vary among specialties and are higher for claims that result in indemnity payments, according to a letter published in the April 5 issue of the New England Journal of Medicine.